Gordon is a member of the Life Sciences Health Industry Group, practicing in the area of health care regulatory law and serving as integration partner for the firm’s China offices. He works closely with the Shanghai and Beijing offices to assist the firm's clients in rapidly accessing our China lawyers.
In coordination with our colleagues in Shanghai and Beijing, Gordon helps pharmaceutical, medical device, health care, and other clients start operations in China, clear regulatory hurdles, develop business ties with Chinese companies, and set up distribution and sales networks.
Gordon chaired the Food and Drug Law Institute Panel on Innovation at its 2011 Beijing conference, and has lectured on Innovation, Regulation, and the Health Care Industry, at the Tsinghua Law School Health Law Research Center (Beijing).
In the United States, Gordon represents device, drug and diagnostic manufacturers on technology reimbursement, obtaining coverage, codes, and payment to advance innovative products before the Centers for Medicare & Medicaid Services ("CMS"), state agencies, and the U.S. Congress. Also, he advises manufacturers and health care providers on compliance with federal and state fraud and abuse laws, including sales, promotional, and marketing programs. Within Reed Smith, Gordon served as co-chair of the firm's Life Sciences Team and Health Care Group Practice Leader.